Welcome to our dedicated page for Bio-Key Intl news (Ticker: BKYI), a resource for investors and traders seeking the latest updates and insights on Bio-Key Intl stock.
BIO-key International, Inc. reports developments in identity and access management software, biometric authentication technology, and related security hardware. The company’s updates center on cloud-hosted and on-premise PortalGuard IAM, biometric-centric multi-factor authentication, Passkey:YOU, and devices such as Pocket 10 Finger Scanners and Mobile POS Pro. Customer news includes software license renewals, public-sector channel partnerships, defense deployments, and retail-bank biometric identification programs.
Financial and corporate updates also cover operating results, revenue contributions from services, license fees, and hardware, Nasdaq listing compliance, periodic-report timing, and share-structure actions such as the company’s 1-for-10 reverse stock split.
BIO-key (NASDAQ: BKYI) announced a significant deployment with a major Middle East defense-sector security organisation on Nov. 7, 2025.
The solution will protect critical infrastructure and sensitive access environments using BIO-key’s biometric and multi-factor authentication, avoiding reliance on mobile devices or hardware tokens. The customer requested anonymity for security reasons. BIO-key said the contract is one of its largest regional security-sector deployments and follows a new strategic partnership with Cloud Distribution to accelerate in-country delivery and opportunities.
BIO-key (NASDAQ: BKYI) entered into a warrant inducement agreement dated Oct 27, 2025, with an existing institutional investor to induce exercise of Series A and Series B warrants originally issued Jan 15, 2025.
The investor agreed to purchase 3,091,668 shares at a reduced exercise price of $1.02 per share, producing gross proceeds of approximately $3.1 million before placement agent fees and offering expenses. Maxim Group is the exclusive placement agent.
As consideration, BIO-key will issue 6,183,336 unregistered new warrants exercisable at $1.02 per share, immediately exercisable and expiring five years from issuance, and will file an SEC registration statement covering resale of shares issuable on exercise.
BIO-key International (NASDAQ: BKYI) announced a partnership with Scandinavian distributor IT2Trust on October 27, 2025 to expand BIO-key’s identity and access management (IAM) and biometric solutions across Denmark, Sweden, Norway, and Finland.
Under the agreement, IT2Trust will distribute and support BIO-key’s full portfolio including PortalGuard (MFA, SSO), Passkey:YOU (FIDO2 passwordless), PIN:You, WEB-key, Identity-Bound Biometrics, and certified scanners PIV-Pro and EcoID III, with a focus on GDPR compliance and public sector and enterprise adoption.
BIO-key (Nasdaq: BKYI) launched the EcoID III USB fingerprint scanner on October 21, 2025, delivering FBI FAP 20, PIV, and NIBSS certifications, plus liveness detection and encrypted device-to-host communication.
EcoID III supports Windows Hello/Windows Hello for Business and FIDO2 Platform authentication, interoperates with over 30 scanners on BIO-key platforms, and offers faster captures, 360-degree placement, LED guidance, and robust performance in bright, wet, and noisy environments. BIO-key says first volume orders are shipping to government customers; availability is via BIO-key and authorized partners.
BIO-key (Nasdaq: BKYI) announced it will exhibit and present at GITEX Global in Dubai (Oct 13–17, 2025) and 19ENISE in León, Spain (Oct 14–16, 2025).
The company will demo Identity-Bound Biometrics (IBB), PortalGuard IAM, and Passkey:YOU, promote passwordless/phoneless/tokenless authentication, and pursue regional partnerships across government, healthcare, and enterprise. BIO-key will host a main-stage presentation and a business networking dinner on Oct 15 in Dubai, and exhibit at Booth 130 in León.
BIO-key International (NASDAQ: BKYI), a provider of Identity and Access Management solutions, reported strong Q2 2025 financial results with revenue increasing 49% to $1.7M. The growth was driven by increases across all segments, with software license fees up 4% to $806K, services revenue rising to $322K, and hardware sales significantly increasing to $569K.
The company launched its BIO-key CyberDefense Initiative to target the growing global defense market, particularly in Europe where EU member states are expected to spend €350B on defense by 2026. Notable Q2 achievements include securing over $600K in follow-on orders from a Foreign Defense Ministry and establishing their first major IAM deployment with a national bank in Mozambique.
Despite the revenue growth, the company reported a net loss of ($1.17M), or ($0.20) per share, though improved from ($1.67M) in Q2'24. Gross margin was 73%, down from 77% year-over-year due to increased hardware sales.
BIO-key International (NASDAQ: BKYI), a provider of Identity and Access Management solutions with biometric authentication capabilities, has scheduled its Q2 2025 earnings conference call for Wednesday, August 13th at 10:00 AM ET. The company will release its financial results before market open on the same day.
The call will be led by Chairman & CEO Mike DePasquale and CFO Cecilia Welch, featuring a Q&A session. Investors can access the call via U.S. dial-in (1-877-418-5460) or international dial-in (1-412-717-9594), with webcast replay available for 3 months.
BIO-key International (NASDAQ: BKYI), a leader in Identity and Access Management (IAM) and biometric authentication solutions, has joined ISMS Forum, Spain's premier cybersecurity association. Through this membership, BIO-key will participate in initiatives focused on identity management, Zero Trust security, and regulatory compliance.
The company will collaborate with ISMS Forum members to shape cybersecurity standards, support compliance with NIS2 and GDPR regulations, and contribute expertise in Identity-Bound Biometrics (IBB), Multi-factor Authentication (MFA), and Single Sign-On (SSO). This strategic move reinforces BIO-key's expanding presence in Spain and commitment to enhancing cybersecurity resilience.
BIO-key International (NASDAQ: BKYI) has announced a strategic partnership with Runlevel, a cybersecurity solutions provider, to expand its Identity and Access Management (IAM) solutions in Portuguese-speaking African countries (PALOP) and Timor-Leste. The partnership has already secured its first major customer - a National Bank in Mozambique, which will implement BIO-key's biometric-based IAM solutions including PortalGuard On-Prem with Multi-factor Authentication and Single Sign-On capabilities.
As part of BIO-key's Channel Alliance Partner program, Runlevel will serve as a Value-Added Reseller, providing pre-sales consulting, deployment support, and technical training tailored to local regulatory requirements. This partnership marks BIO-key's strategic expansion into Portuguese-speaking markets and strengthens its position in the global financial sector.